Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EP-7327
- Development stage
- Preclinical
- Lead developer
- Cadrenal Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**EP-7327** is an investigational *oral small molecule* drug that acts as a potent and selective inhibitor of **Factor XIa (F11)**, a serine protease involved in the intrinsic pathway of blood coagulation. EP-7327 is being developed for the prevention and treatment of major thrombotic conditions, with its primary indication focused on **thrombosis**. By selectively targeting Factor XIa, EP-7327 aims to reduce the risk of clot formation while minimizing bleeding, a known risk of many current anticoagulants. The drug is IND-ready for chronic antithrombotic indications and represents a promising new class of anticoagulants under research. EP-7327 was originally developed by **eXIthera Pharmaceuticals** and is now under development by **Cadrenal Therapeutics** following acquisition[1][3][9].
- Other names
- EP-7327EP7327EP 7327
02
Targets
Factor XIa
Beyond the preview
Go deeper on EP-7327.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EP-7327.